Effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines: What does the literature say?

被引:7
|
作者
Alvarez Aldean, Javier [1 ]
Salamanca, Ignacio [2 ]
Ocana, Daniel [3 ]
Luis Barranco, Jose [4 ]
Walter, Stefan [5 ]
机构
[1] Hosp Costa del Sol, Pediat Dept, Malaga, Spain
[2] Inst Hispalense Pediat, Studies & Res Unit, Seville, Spain
[3] Hlth Ctr, Algeciras Norte, Cadiz, Spain
[4] Hosp Reina Sofia, Med Prevent, Cordoba, Spain
[5] Univ Rey Juan Carlos, Dept Med Specialties & Publ Hlth, Emerging Res Epidemiol & Diag Infect Dis, Madrid, Spain
关键词
Influenza; influenza virus; egg-based vaccine; cell culture-based vaccine; DOUBLE-BLIND; PHASE-III; IMMUNOGENICITY; MULTICENTER; VIRUSES; SAFETY;
D O I
10.37201/req/117.2021
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction. Influenza vaccination is an effective way of reducing the burden of seasonal influenza. Chicken egg embryos are the most common source of influenza vaccines, but cell culture production has emerged as an alternative that could be advantageous. This article reviews the available literature on the efficacy/effectiveness of cell culture-based influenza vaccines compared with egg-based vaccines. Methods. We conducted a review of the actual literature and analyzed those studies comparing the effectiveness of cell culture-based and egg-based vaccines in the last ten years. Results. Eight studies were analyzed; 1 was a clinical trial and 7 were retrospective cohort studies. The clinical trial found no significant differences in the efficacy of both vaccines with respect to placebo. The results of the observational studies were inconsistent and relative effectiveness varied among studies, even though most were performed during the same season, and in some cases, in the same region and using the same data records. Furthermore, in most studies, the comparisons between vaccines were not statistically significant. Conclusions. There is insufficient evidence that cell culture-based vaccines are superior to egg-based vaccines in terms of efficacy/effectiveness.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 50 条
  • [1] Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to egg-based trivalent high dose and other egg-based vaccines
    Pelton, S.
    Postma, M.
    Divino, V.
    Mould, J.
    Dekoven, M.
    Krishnarajah, G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 465 - 465
  • [2] Safety of MDCK cell culture-based influenza vaccines
    Gregersen, Jens-Peter
    Schmitt, Heinz-Josef
    Trusheim, Heidi
    Broeker, Michael
    FUTURE MICROBIOLOGY, 2011, 6 (02) : 143 - 152
  • [3] Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines
    Feng Liu
    F. Liaini Gross
    Sneha Joshi
    Manjusha Gaglani
    Allison L. Naleway
    Kempapura Murthy
    Holly C. Groom
    Meredith G. Wesley
    Laura J. Edwards
    Lauren Grant
    Sara S. Kim
    Suryaprakash Sambhara
    Shivaprakash Gangappa
    Terrence Tumpey
    Mark G. Thompson
    Alicia M. Fry
    Brendan Flannery
    Fatimah S. Dawood
    Min Z. Levine
    Nature Communications, 15
  • [4] Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines
    Liu, Feng
    Gross, F. Liaini
    Joshi, Sneha
    Gaglani, Manjusha
    Naleway, Allison L.
    Murthy, Kempapura
    Groom, Holly C.
    Wesley, Meredith G.
    Edwards, Laura J.
    Grant, Lauren
    Kim, Sara S.
    Sambhara, Suryaprakash
    Gangappa, Shivaprakash
    Tumpey, Terrence
    Thompson, Mark G.
    Fry, Alicia M.
    Flannery, Brendan
    Dawood, Fatimah S.
    Levine, Min Z.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [5] Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017-2018
    Bruxvoort, Katia J.
    Luo, Yi
    Ackerson, Bradley
    Tanenbaum, Hilary C.
    Sy, Lina S.
    Gandhi, Ashesh
    Tseng, Hung Fu
    VACCINE, 2019, 37 (39) : 5807 - 5811
  • [6] Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020
    Naleway, Allison L.
    Kim, Sara S.
    Flannery, Brendan
    Levine, Min Z.
    Murthy, Kempapura
    Sambhara, Suryaprakash
    Gangappa, Shivaprakash
    Edwards, Laura J.
    Ball, Sarah
    Grant, Lauren
    Zunie, Tnelda
    Cao, Weiping
    Gross, F. Liaini
    Groom, Holly
    Fry, Alicia M.
    Hunt, Danielle
    Jeddy, Zuha
    Mishina, Margarita
    Wesley, Meredith G.
    Spencer, Sarah
    Thompson, Mark G.
    Gaglani, Manjusha
    Dawood, Fatimah S.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (06):
  • [7] Cell culture-based influenza vaccines: A necessary and indispensable investment for the future
    Hegde, Nagendra R.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (05) : 1223 - 1234
  • [8] Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among US adults
    Boyce, Thomas G.
    Levine, Min Z.
    Mcclure, David L.
    King, Jennifer P.
    Flannery, Brendan
    Nguyen, Huong Q.
    Belongia, Edward A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [9] Cost-effectiveness analysis of cell-based versus egg-based quadrivalent influenza vaccines in the pediatric population in Taiwan
    Chi, Chia-Yu
    Cheng, Ming-Fang
    Ko, Karam
    Mould, Joaquin F.
    Chen, Chih-Jung
    Huang, Yhu-Chering
    Lee, Ping-Ing
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (01)
  • [10] Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain
    Ruiz-Aragon, Jesus
    Gani, Ray
    Marquez, Sergio
    Alvarez, Piedad
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2238 - 2244